Continue to Site

Johnson & Johnson is bringing the world’s first drug-eluting contact lens to market

March 21, 2022 By Sean Whooley

Theravision_FDA Revised Carton

Johnson & Johnson has a potential alternative to eye drops with its drug-eluting Acuvue Theravision contact lens.

As far back as the early 1960s, researchers toyed with the idea of delivering medication through contact lenses.

Johnson & Johnson Vision (NYSE:JNJ) Director of Clinica Science Dr. Brian Pall told Drug Delivery Business News that patents back then disclosed how a soft contact lens of hydrogel material could be an effective vehicle for delivering medication to the eye.

Get the full story at our sister site, Drug Delivery Business News.

About The Author

Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.